Biggest News Aggregation in the World
📰 About Rhythm News

About Rhythm News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from About Rhythm. Real-time updates on events, politics, business and more.

Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology

- Publication highlights administration of setmelanotide therapy resulted in a mean percent reduction in BMI of 15% at 16 weeks and 26% at one year of treatment - - Topline data from ongoing pivotal...
United Kingdom United States David Connolly Christian Roth Adam Daley Seattle Children Research Institute

Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Receives Positive CHMP Opinion for Setmelanotide for Treatment of Obesity and Control of Hunger Associated with POMC, PCSK1 and LEPR Deficiency

European Commission decision anticipated in JulyBOSTON, May 21, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming
United States France General Adam Daley Hannah Deresiewicz David Meeker David Connolly

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science